Form 8-K - Current report:
SEC Accession No. 0001013762-24-002270
Filing Date
2024-07-30
Accepted
2024-07-30 08:00:33
Documents
15
Period of Report
2024-07-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210232-8k_180lifesci.htm   iXBRL 8-K 30134
2 PRESS RELEASE, DATED JULY 30, 2024 ea021023201ex99-1_180life.htm EX-99.1 21509
  Complete submission text file 0001013762-24-002270.txt   280148

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20240730.xsd EX-101.SCH 3787
4 XBRL DEFINITION FILE atnf-20240730_def.xml EX-101.DEF 26629
5 XBRL LABEL FILE atnf-20240730_lab.xml EX-101.LAB 36680
6 XBRL PRESENTATION FILE atnf-20240730_pre.xml EX-101.PRE 25253
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0210232-8k_180lifesci_htm.xml XML 5806
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 241154437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)